Glucagon‐like peptide‐1 receptor agonists to expand the healthy lifespan: Current and future potentials

To help ensure an expanded healthy lifespan for as many people as possible worldwide, there is a need to prevent or manage a number of prevalent chronic diseases directly and indirectly closely related to aging, including diabetes and obesity. Glucagon‐like peptide 1 receptor agonists (GLP‐1 RAs) ha...

Descripción completa

Detalles Bibliográficos
Autores principales: Kreiner, Frederik Flindt, von Scholten, Bernt Johan, Kurtzhals, Peter, Gough, Stephen Charles Langford
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10186594/
https://www.ncbi.nlm.nih.gov/pubmed/37191234
http://dx.doi.org/10.1111/acel.13818

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10186594/
https://www.ncbi.nlm.nih.gov/pubmed/37191234
http://dx.doi.org/10.1111/acel.13818

Ejemplares similares